Analyst picks & changes
By BC Staff | Aug 20, 2007 | 7:00 AM GMT
Analyst picks & changes
| Analyst picks & changes |
| Company | Bank | Analyst | Coverage | Opinion | Wk chg | 8/17 cls |
| Acusphere (ACUS) | Susquehanna | Angela Larson | Downgrade | Neutral (from net positive) | -5% | $1.62 |
| Larson noted that an NDA submission and subsequent approval of Imagify gas-filled polymer microsphere ultrasound contrast agent could take more than 18 months, based on a lack of clarity on "accuracy" as an FDA-validated clinical endpoint (see BioCentury, May 7). |
| Aeterna Zentaris (TSX:AEZ; AEZS) | Dundee | David Martin | Rating change | Speculative buy | -4% | $2.51 |
| Martin changed his rating to "speculative buy" from "under review." He believes there is "relatively low risk" that trials conducted by Solvay
|
Read the full 1049 word article
